Skip to main content
. 2018 Oct 1;19:345. doi: 10.1186/s12859-018-2392-y

Fig. 2.

Fig. 2

Characterizing GPCRs and endogenous ligands. a Number of endogenous ligands per GPCR and (b) number of GPCRs per endogenous ligand. c Average number of gene-disease pairs by GPCR, endogenous ligand, and all other target types using all pairs (left) and pairs with overall score > 0.5 (right). d Distribution of overall scores by target type (GPCR, endogenous ligand, and all other)